Nonetheless, only a fool would ignore the risk that a loss making company burns through its cash too quickly. So, the natural question for CRISPR Therapeutics (NASDAQ:CRSP) shareholders is whether ...

The cover of Time Magazine’s May edition features a striking image of a large, white wolf. Above it, the word “extinct” in ...

Beam Therapeutics and Verve Therapeutics have each built their lead candidates on a technique billed as a safer alternative ...

CRISPR Therapeutics and Intellia face 2025 volatility, but CRSP’s strong cash and launches make it more attractive than NTLA.

Union Minister of Agriculture and Farmers’ Welfare Shivraj Singh Chouhan released the two rice varieties at the ICAR’s NASC ...

Dibrugarh: Looking to further India's efforts to eliminate tuberculosis, the ICMR-Regional Medical Research Centre, North ...

A research team has uncovered a previously unknown type of immune signaling molecule—a novel compound combining histidine and ...